Walgreens Boots Alliance Inc (WBA) Shares Sold by Fmr LLC

Fmr LLC reduced its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 20.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,975,292 shares of the pharmacy operator’s stock after selling 1,012,057 shares during the quarter. Fmr LLC’s holdings in Walgreens Boots Alliance were worth $238,577,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Squar Milner Financial Services LLC acquired a new stake in Walgreens Boots Alliance during the second quarter worth about $106,000. Kaizen Advisory LLC grew its position in Walgreens Boots Alliance by 128.6% during the second quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after buying an additional 1,083 shares in the last quarter. Camarda Financial Advisors LLC acquired a new stake in Walgreens Boots Alliance during the second quarter worth about $137,000. Sun Life Financial INC grew its position in Walgreens Boots Alliance by 803.5% during the second quarter. Sun Life Financial INC now owns 2,313 shares of the pharmacy operator’s stock worth $139,000 after buying an additional 2,057 shares in the last quarter. Finally, Wagner Wealth Management LLC grew its position in Walgreens Boots Alliance by 111.0% during the second quarter. Wagner Wealth Management LLC now owns 2,623 shares of the pharmacy operator’s stock worth $157,000 after buying an additional 1,380 shares in the last quarter. 64.81% of the stock is currently owned by institutional investors.

NASDAQ:WBA opened at $79.77 on Thursday. Walgreens Boots Alliance Inc has a 1 year low of $59.07 and a 1 year high of $80.68. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.82 and a quick ratio of 0.38. The company has a market capitalization of $72.35 billion, a PE ratio of 13.25, a PEG ratio of 1.20 and a beta of 1.04.



Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.45 by $0.03. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. The company had revenue of $33.44 billion during the quarter, compared to analysts’ expectations of $33.64 billion. As a group, sell-side analysts anticipate that Walgreens Boots Alliance Inc will post 6.53 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th will be paid a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.21%. The ex-dividend date is Thursday, November 8th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 29.24%.

A number of equities research analysts recently weighed in on the company. TheStreet raised Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research report on Wednesday, September 12th. ValuEngine upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, September 21st. BidaskClub upgraded shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, August 21st. Cowen cut shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating and set a $104.00 price target for the company. in a research note on Monday, July 23rd. Finally, Pivotal Research raised their price target on shares of Walgreens Boots Alliance from $60.00 to $72.00 and gave the stock a “hold” rating in a research note on Monday, October 15th. One analyst has rated the stock with a sell rating, eleven have given a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $78.22.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Further Reading: What does EPS mean?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply